AYTU BIOPHARMA, INC Form PRE 14C: Preliminary information statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-02-10: Form PRE 14C; Period of report 2011-02-09; Description ROSEWIND CORP PRELIMINARY - NOTICE OF STOCKHOLDER ACTION; Document prelim14c.txt.
- 2010-06-29: Form PRE 14C; Period of report 2010-06-29; Description ROSEWIND CORP PRELIMINARY 14(C) INFORMATION STMT; Document infostmt14c.txt.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2011-02-10 | PRE 14C | 2011-02-09 | ROSEWIND CORP PRELIMINARY - NOTICE OF STOCKHOLDER ACTION | prelim14c.txt |
| 2010-06-29 | PRE 14C | 2010-06-29 | ROSEWIND CORP PRELIMINARY 14(C) INFORMATION STMT | infostmt14c.txt |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |